BioSniper
ZH
Toggle language
Open menu
Patent Expiry
Patent/Exclusivity Expiry: ESOMEPRAZOLE MAGNESIUM
December 8, 2036
Company
Keros Therapeutics, Inc. (KROS)
Drug
ESOMEPRAZOLE MAGNESIUM
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
KROS Overview
PDUFA Dates
Phase 3 Readouts
Patent/Exclusivity Expiry: ESOMEPRAZOLE MAGNESIUM — KROS Patent Expiry | BioSniper